![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
ME Charness, G Hu, RH Edwards and LA Querimit
Department of Neurology, Harvard Medical School, West Roxbury Veterans Affairs Medical Center, MA 02132.
Long-term treatment with ethanol increases delta-opioid receptor (DOR) expression in the NG108-15 neuroblastoma x glioma hybrid cell line. To determine the underlying mechanism, we studied the effects of ethanol on [3H]diprenorphine binding to intact cells and DOR gene expression in four related clonal neural cell lines. Incubation with 200 mM ethanol for 48 hr increased [3H]diprenorphine binding by 1.4- (N18TG2), 1.8- (NG108-15), 1.9- (N4TG1), and 3.0-fold (N1E-115). Treatment with 25, 50, or 100 mM ethanol for 1 week caused a dose-dependent increase in receptor expression. Receptor up-regulation was associated with an increase in the potency of etorphine for inhibiting prostaglandin E1- stimulated cAMP accumulation. Constitutive DOR expression differed more than 3-fold among the different cell lines and correlated positively with basal cAMP levels. Long-term ethanol treatment increased basal cAMP levels in three of the four cell lines, but did not induce cellular differentiation. Northern blot analysis demonstrated an identical pattern of multiple transcripts in the four cell lines. Ethanol increased the abundance of DOR mRNA by approximately 3-fold in N18TG2 cells and by approximately 5-fold in the remaining cell lines. These findings indicate that clinically relevant concentrations of ethanol regulate DOR expression by increasing the abundance of DOR mRNA. The disparity between the increase in gene expression and ligand binding suggests that ethanol may also modify mRNA translation or receptor processing.
This article has been cited by other articles:
|
|
 |
|
  E. D. Marczak, Y. Jinsmaa, T. Li, S. D. Bryant, Y. Tsuda, Y. Okada, and L. H. Lazarus [N-Allyl-Dmt1]-Endomorphins Are {micro}-Opioid Receptor Antagonists Lacking Inverse Agonist Properties J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 374 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Smirnov, H.-J. Im, and H. H. Loh delta -Opioid Receptor Gene: Effect of Sp1 Factor on Transcriptional Regulation in Vivo Mol. Pharmacol., August 1, 2001; 60(2): 331 - 340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Gordon, L. Yao, Z.-L. Wu, I. R. Coe, and I. Diamond Ethanol Alters the Subcellular Localization of delta - and epsilon Protein Kinase C in NG108-15 Cells Mol. Pharmacol., October 1, 1997; 52(4): 554 - 559. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. Sun and H. H. Loh Transcriptional Regulation of Mouse delta -Opioid Receptor Gene. ROLE OF Ets-1 IN THE TRANSCRIPTIONAL ACTIVATION OF MOUSE delta -OPIOID RECEPTOR GENE J. Biol. Chem., November 21, 2001; 276(48): 45462 - 45469. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
